Illumina Inc Stock Price and Quote (2024)

Held by: VTI VOO VO QQQ IVV VUG IBB VOT RSP VHT

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-7.34	Insider Own	0.45%	Shs Outstand	159.00M	Perf Week	-3.61%
Market Cap	21.52B	Forward P/E	54.92	EPS next Y	2.47	Insider Trans	0.99%	Shs Float	158.19M	Perf Month	-5.25%
Income	-1161.00M	PEG	-	EPS next Q	0.04	Inst Own	91.12%	Short Float	3.03%	Perf Quarter	18.81%
Sales	4.50B	P/S	4.78	EPS this Y	1.94%	Inst Trans	2.73%	Short Ratio	2.42	Perf Half Y	-14.74%
Book/sh	36.13	P/B	3.75	EPS next Y	181.28%	ROA	-10.38%	Short Interest	4.79M	Perf Year	-34.90%
Cash/sh	6.63	P/C	20.42	EPS next 5Y	22.90%	ROE	-18.81%	52W Range	89.00 - 238.55	Perf YTD	-2.74%
Dividend Est.	-	P/FCF	76.31	EPS past 5Y	-	ROI	-14.66%	52W High	-43.23%	Beta	1.19
Dividend TTM	-	Quick Ratio	1.29	Sales past 5Y	7.40%	Gross Margin	60.97%	52W Low	52.17%	ATR (14)	5.23
Dividend Ex-Date	-	Current Ratio	1.66	EPS Y/Y TTM	73.83%	Oper. Margin	-1.62%	RSI (14)	45.53	Volatility	3.07% 4.02%
Employees	12010	Debt/Eq	0.39	Sales Y/Y TTM	-1.72%	Profit Margin	-25.78%	Recom	2.38	Target Price	153.57
Option/Short	Yes / Yes	LT Debt/Eq	0.38	EPS Q/Q	-24.92%	Payout	-	Rel Volume	0.97	Prev Close	136.00
Sales Surprise	3.19%	EPS Surprise	652.69%	Sales Q/Q	3.60%	Earnings	Feb 08 AMC	Avg Volume	1.98M	Price	135.43
SMA20	-2.27%	SMA50	-2.69%	SMA200	-10.08%	Trades		Volume	1,918,967	Change	-0.42%

open in yahoo|&nbspopen in reuters|&nbspopen in marketwatch|&nbspopen in google|&nbspopen in EDGAR

Date	Action	Analyst	Rating Change	Price Target Change
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170
Dec-14-23	Initiated	Guggenheim	Buy	$155
Dec-13-23	Initiated	Wolfe Research	Outperform	$175
Dec-12-23	Downgrade	BofA Securities	Neutral → Underperform	$140 → $100
Dec-11-23	Upgrade	Citigroup	Sell → Neutral	$85 → $120
Nov-10-23	Downgrade	Canaccord Genuity	Buy → Hold	$210 → $120
Sep-28-23	Initiated	Bernstein	Underperform	$111
Jul-05-23	Resumed	JP Morgan	Neutral	$235
Jan-25-23	Downgrade	Argus	Buy → Hold
Jan-05-23	Initiated	Scotiabank	Sector Perform	$216
Dec-12-22	Downgrade	Citigroup	Neutral → Sell	$200 → $180
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$282
Oct-04-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$220 → $270
Sep-28-22	Upgrade	Evercore ISI	In-line → Outperform	$170 → $250
Aug-25-22	Initiated	Credit Suisse	Neutral	$230
Jul-13-22	Downgrade	Barclays	Equal Weight → Underweight	$350 → $150

Show Previous Ratings

Today 09:45AM	Finding the Needle in the Genomic Haystack With DRAGEN (ACCESSWIRE)
Mar-07-24 09:45AM	Video: Give Someone a Fish, You Feed Them - Unlock the Fish Genome, You Feed the World (ACCESSWIRE)
Mar-02-24 02:30PM	FTC's suit against Kroger-Albertsons merger will have a 'chilling effect' on M&A activity (Yahoo Finance)
Feb-28-24 05:52AM	Reasons for the Decline of Illumina (ILMN) (Insider Monkey)
Feb-27-24 03:40AM	Do You Believe in the Growth Prospects of Illumina (ILMN)? (Insider Monkey)
03:09AM	Jenny Zheng joins Illumina as Senior Vice President and General Manager of Greater China (PR Newswire)
Feb-26-24 06:29PM	Why Illumina Stock Mashed the Market on Monday (Motley Fool)
11:00AM	Illumina Inc CEO Jacob Thaysen Acquires 7,330 Shares (GuruFocus.com)
Feb-24-24 06:50AM	15 Best Shareholder Activism Law Firms (Insider Monkey)
Feb-23-24 07:59AM	Activist Investor Alert: The Top 3 Stocks Carl Icahn Is Targeting in 2024 (InvestorPlace)
Feb-21-24 07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:00AM	Icahn Enterprises L.P. Announces Management & Financial Update (PR Newswire)
Feb-20-24 10:25AM	Illumina (ILMN) Rides on NGS Portfolio Expansion Amid Macro Woe (Zacks)
Feb-14-24 07:00PM	Illumina, already facing pressure from Icahn, saw other activists at year end (Reuters) +5.23%
09:40AM	Illumina Named One of Americas Most JUST Companies and Included in the 2024 S&P Global Sustainability Yearbook (ACCESSWIRE)
Feb-09-24 11:19AM	Illumina, Inc. (NASDAQ:ILMN) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:52AM	Q4 2023 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
07:39AM	Illumina (ILMN) Q4 Earnings Surpass Estimates, Margin Down (Zacks)
05:45AM	Illumina cut 12% of global staff over past year: CEO (MedTech Dive)
01:32AM	Analyst Report: Illumina, Inc. (Morningstar Research)
Feb-08-24 06:30PM	Illumina (ILMN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
05:24PM	Illumina forecasts flat 2024 sales as sluggish demand drags on (Reuters)
04:34PM	Illumina Inc (ILMN) Reports Mixed Fiscal Year 2023 Results Amidst GRAIL Divestiture (GuruFocus.com)
04:24PM	Illumina: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023 (PR Newswire)
09:14AM	Illumina to lay off 111 people at San Diego headquarters (MedTech Dive)
Feb-05-24 09:16AM	Seeking Clues to Illumina (ILMN) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Feb-01-24 09:10PM	Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements (InvestorPlace)
Jan-30-24 07:31AM	Illumina (ILMN) Leads the Market With 80% Share (Insider Monkey)
Jan-29-24 07:49PM	Analyst Report: Illumina, Inc. (Morningstar Research)
Jan-28-24 09:25AM	3 Stocks to Buy for the Age of Personalized Medicine (InvestorPlace)
Jan-23-24 08:45PM	Cramer's Lightning Round: Fluor, Illumina and Ferrari (CNBC TV)
Jan-19-24 08:25AM	Heres Why Polen Focus Growth Sold Illumina (ILMN) (Insider Monkey)
Jan-18-24 07:52AM	Here's How the New AI Algorithm Helps Illumina (ILMN) (Insider Monkey)
05:04AM	The Top 3 Stocks in the High-Potential Cancer Testing Market (InvestorPlace)
Jan-17-24 12:04PM	7 Mighty Healthcare Stocks Changing the Game of Medicine (InvestorPlace)
Jan-16-24 10:11AM	Illumina (ILMN) Shares Down 1.2% Post Preliminary Q4 Results (Zacks)
Jan-15-24 07:00AM	Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world (PR Newswire)
Jan-12-24 09:45AM	What 5000 Ancient Human Genomes Can Reveal About European Health and Heritage (ACCESSWIRE)
Jan-11-24 09:45AM	What Happens When a Virus Becomes a Permanent Part of Your Genome? (ACCESSWIRE)
Jan-09-24 05:28PM	Match Group, Juniper- HPE talks, Illumina: Trending Tickers (Yahoo Finance Video)
02:02PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:00AM	Illumina Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2023 (PR Newswire)
07:05AM	Why Illumina Rallied 36.6% in December (Motley Fool)
05:38AM	Illumina unveils preliminary fourth-quarter revenue that tops estimates (Investing.com)
03:34AM	Susan Tousi leaves Illumina to become CEO of liquid biopsy firm Delfi (MedTech Dive)
Jan-08-24 12:45PM	Illumina (ILMN) Extends Partnership to Advance Cancer Test (Zacks)
Jan-05-24 09:15AM	Illumina expands collaboration with Janssen to advance molecular residual disease cancer test (PR Newswire)
Jan-04-24 08:17PM	Illumina's story is too messy and uncertain right now, says Jim Cramer (CNBC TV)
04:05PM	Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024 (PR Newswire)
09:15AM	The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk (PR Newswire)
Dec-28-23 01:02PM	Here's Why You Should Retain Illumina (ILMN) Stock for Now (Zacks)
Dec-27-23 10:45AM	ILLUMINA SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Illumina To Contact Him Directly To Discuss Their Options (GlobeNewswire)
Dec-22-23 03:00PM	Final Deadline Approaching for Illumina, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Illumina, Inc. (ILMN) Investors of January 9, 2024 Lead Plaintiff Deadline (GlobeNewswire)
Dec-21-23 09:35AM	Nucleus Genomics Wants To Make Personalized Health Care a Reality (ACCESSWIRE)
Dec-19-23 05:28PM	Heard on the Street: Illumina Nears the End of Its Painful Grail Saga (The Wall Street Journal) +8.08%
04:42PM	S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar Stocks (Investopedia)
04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
01:26PM	FTC, DOJ finalize merger guidelines that could impede healthcare M&A (Healthcare Dive)
11:11AM	Hedge Fund and Insider Trading News: Jim Chanos, Carl Icahn, Tiger Global Management, Odey Asset Management, Cevian Capital, Heritage Insurance Holdings Inc (HRTG), and More (Insider Monkey)
11:02AM	Carl Icahn to initiate proxy battle with Illumina again (Yahoo Finance Video)
09:45AM	A Lesser-Known Application of Genomics: Reducing Cow Burp Intensity (ACCESSWIRE)
05:30AM	The 2023 stock market rally isn't just about seven stocks anymore (Yahoo Finance)
05:30AM	The 2023 stock market rally isn't just about 7 stocks anymore (Yahoo Finance)
05:18AM	Grail CEO predicts transformative 2024 amid Illumina split (MedTech Dive)
12:00AM	Could the trustbusters be making a comeback? (Financial Times)
Dec-18-23 04:17PM	These Stocks Are Moving the Most Today: U.S. Steel, Apple, Adobe, SunPower, VF Corp, NIO, and More (Barrons.com)
04:07PM	Illumina Ends Its Controversial Grail Battle With A Divestiture; Shares Rise (Investor's Business Daily)
03:37PM	US Steel & Nippon, Adobe, Illumina: Top M&A announcements (Yahoo Finance Video)
01:55PM	Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years (Benzinga)
12:46PM	Illumina Gives Up Fight With Regulators, Will Divest GRAIL (Investopedia)
12:11PM	These Stocks Are Moving the Most Today (Barrons.com)
10:58AM	Activist Icahn prepares a second board challenge at Illumina -letter (Reuters)
09:45AM	Illumina Stock Rises On Plans To Divest Controversial Buyout Grail (Investor's Business Daily)
09:42AM	Stocks to Watch Monday: U.S. Steel, Apple, Illumina, NIO (The Wall Street Journal)
09:25AM	3 Charts For Investors to Watch Monday: Illumina, Roku, Bitcoin (Investopedia)
08:57AM	'Wonka' tops the box office, Illumina to divest Grail (CNBC TV)
07:20AM	Illumina To Sell Grail After U.S. Antitrust Ruling (Investor's Business Daily)
06:38AM	Treasury Yield Curve May Flip in 2024. The Fallout for Recession and Stocks. (Barrons.com)
04:48AM	Illumina to Sell Grail. Its Giving Up on Its Biotech Antitrust Battle. (Barrons.com)
02:48AM	US Steel, Illumina, Nio rise premarket; Apple, Southwest, Roku fall (Investing.com)
02:00AM	PRESS DIGEST- New York Times business news - Dec 18 (Reuters)
01:47AM	Illumina rises premarket after gene-sequencing group announces Grail divestiture (Investing.com)
01:30AM	PRESS DIGEST- Wall Street Journal - Dec 18 (Reuters)
01:24AM	Futures edge up, Illumina to divest Grail - what's moving markets (Investing.com)
Dec-17-23 08:16PM	Illumina to Shed Cancer-Test Maker Grail After Antitrust Battle (The Wall Street Journal)
08:16PM	Illumina to Divest Itself of Cancer-Test Maker Grail (The Wall Street Journal)
07:42PM	Analyst Report: Illumina, Inc. (Morningstar Research)
06:17PM	Biotech giant Illumina will unwind takeover of cancer-screening company Grail (Associated Press Finance)
03:38PM	REFILE-UPDATE 3-Illumina to divest cancer test maker Grail after antitrust battles (Reuters)
02:50PM	Illumina to divest cancer test maker Grail after antitrust battles (Reuters)
02:45PM	Illumina to divest cancer test maker Grail (Reuters)
02:37PM	Illumina Announces Decision to Divest GRAIL (PR Newswire)
Dec-16-23 02:32PM	Court Sides With FTC Finding Illumina-Grail Deal Anticompetitive (The Wall Street Journal)
Dec-15-23 07:07PM	US court strikes down FTC order against Illumina's purchase of Grail (Reuters)
07:01PM	UPDATE 4-US court orders new FTC review of Illumina's Grail deal (Reuters)
09:39AM	GE upgraded, Northrop Grumman downgraded: Wall Street's top analyst calls (The Fly)
Dec-13-23 05:02AM	Illumina prepares to divest Grail with Form 10 filing (MedTech Dive) +7.68%
Dec-12-23 09:47PM	Illumina, Inc. investors: Please contact the Portnoy Law Firm to recover your losses (GlobeNewswire)
12:45PM	Illumina Named to the Dow Jones Sustainability Indices for the Fifth Consecutive Year (ACCESSWIRE)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Thaysen Jacob	Chief Executive Officer	Feb 22 '24	Buy	135.29	7,330	991,672	14,861	Feb 26 08:57 AM
Hoyt Aimee L	SVP, Chief People Officer	Nov 07 '23	Sale	112.84	315	35,545	8,314	Nov 09 04:22 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Aug 22 '23	Sale	167.04	500	83,520	45,524	Aug 24 04:19 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jul 24 '23	Sale	190.08	500	95,040	46,022	Jul 26 06:14 PM
TOUSI SUSAN H	SVP, Chief Commercial Officer	Jun 22 '23	Sale	200.00	500	100,000	46,522	Jun 26 05:23 PM
EPSTEIN ROBERT S	Director	May 25 '23	Option Exercise	71.09	7,600	540,284	14,764	May 25 04:34 PM

Upgrade your FINVIZ experience

Join thousands of traders who make more informed decisions withourpremium features. Real-time quotes, advancedvisualizations, backtesting, and much more.

Learn more about FINVIZ*Elite